Skip to content

MarketAxess MKTX Repayments of Short-Term Debt

Repayments of Short-Term Debt at other companies

Elevance Health logo
Elevance HealthELV
$150M+30.4%
Boston Scientific logo
Boston ScientificBSX
$259M-76.1%
Vistra logo
VistraVST
$1.42B
Chubb logo
ChubbCB
$1.92B+329%
Vulcan Materials Company logo
Vulcan Materials CompanyVMC
$50M
McKesson logo
McKessonMCK
$6.97B+14.0%

Other financials

Income statement

See full
Revenue$233.4M+11.9%
Operating income$100.9M+14.2%
Net income$77.9M+417%
EPS (diluted)$2.20+450%

Balance sheet

See full
Cash & equivalents$548.2M-14.9%
Total debt$292.0M+312%
Total equity$1.2B-11.6%
Total assets$2.3B+22.5%

Cash flow

See full
Operating cash flow-$75.3M-354%
CapEx$259.0K-86.6%
Free cash flow-$75.6M-373%

Valuation

See full
Market cap$4.2B-28.1%

Profitability

See full
Operating margin40.7%-0.6pp
Net margin35.5%+9.0pp
FCF margin31.1%-19.1pp

Returns & leverage

See full
Return on equity24.4%+8.1pp
Debt / equity0.2×+0.2×

Where this comes from

Reported directly by MarketAxess in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfShortTermDebt.

The official record: MarketAxess’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MarketAxess's repayments of short-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MarketAxess's repayments of short-term debt?
MarketAxess (MKTX) reported repayments of short-term debt of $118M in Q1 2026.
What is the long-term trend for MarketAxess's repayments of short-term debt?
Over 2 years (2022 to 2025), MarketAxess's repayments of short-term debt has grown at a -100.0% compound annual growth rate (CAGR), from $100M to $0.